“Management of Rheumatologic Immune-Related Adverse Events (Rh-irAEs) – An Overview of Immunosuppressive Therapies”, Can Rheumatol Today, vol. 1, no. 1, pp. 34–39, Apr. 2024, doi: 10.58931/crt.2024.1147.